A novel urokinase plasminogen activator receptor-targeted peptide-based probe for in-vivo molecular imaging of glioblastoma

aDepartment of Nuclear Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

bDepartment of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

cKey Laboratory of Pesticides and Chemical Biology, Ministry of Education, College of Chemistry, Central China Normal University

dDepartment of Radiology, Zhongnan Hospital of Wuhan University

eDepartment of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Received 16 September 2022 Accepted 7 November 2022.

*Yunfeng Han and Le Tu contributed equally to the writing of this article.

Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website, www.nuclearmedicinecomm.com.

Correspondence to Ziyan Sun, MD, Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan 430030, China, Tel: +86 (27) 83663881; e-mail: [email protected]

留言 (0)

沒有登入
gif